The Study on the Evaluation of Acupuncture Therapy on Primary Insomnia

Sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05830877
Collaborator
(none)
74
2
32

Study Details

Study Description

Brief Summary

Through the recruition of outpatients who clinically meet the diagnostic criteria and inclusion criteria of PI, the treatment group adopts mind-regulating acupuncture, and the control group adopts routine acupuncture, and the Pittsburgh Sleep Quality Index (PSQI) is used as the main index to evaluate the patients through the scale; subjective indicators like Chalder 14-item fatigue scale, Epworth sleepiness rating, self-rating anxiety scale (SAS), self-rating depression scale (SDS) and objective indicators like polysomnography (PSG), heart rate variability (HRV) is regarded as a secondary index, and then evaluate the clinical efficacy of Tiaoshen acupuncture on PI and explore its mechanism.

Condition or Disease Intervention/Treatment Phase
  • Other: the tiaoshen acupuncture
  • Other: the common acupuncture
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
74 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The RCT Study on the Evaluation of Clinical Effect of Primary Insomnia Treated With the Tiaoshen Acupuncture
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: the treatment group

the patients included in this arm will recept the tiaoshen acupuncture.

Other: the tiaoshen acupuncture
The primary choice is to puncture GB20 with a quick puncture, which means "regulate the mind and open the way". ①Scalp acupuncture: Du 20(Baihui), EX-HN 3(Yintang), EX-HNl(Sishencong); ②Select acupoints from six acupoints for mind-regulating, ear points (both sides): heart, lung, and Shenmen; body points (both sides): LI20(Yingxiang), EXTRA 12(Anmian), ST36(Zusanli) as the main hole. ③Sleeping three needles(both sides): HT7(Shenmen), PC6(Neiguan), SP6(Sanyinjiao); ④Opening four gates: LI4(Hegu) , LR3(Taichong) ⑤Abdominal four needles:ST25(Tianshu), CV12(Zhongwan), CV4(Guanyuan). For body acupuncture, a 0.3 mm×40 mm needle was used to insert directly for 0.5-1.0 cun, and twisting to gain the qi; for auricular points, a 0.25 mm×40 mm needle was used for 2-3 minutes without manipulating the needle. The acupuncture points were retained for 30 min, and the treatment was performed once every other day, three times a week, and the curative effect was evaluated after 4 weeks of treatment.

Active Comparator: the control group

the patients included in this arm will recept treatment of acupuncture which described in book of Acupuncture and Moxibustion (the fifth edition of the new century)

Other: the common acupuncture
According to the "Insomnia" section in the textbook "Acupuncture and Moxibustion (New Century Fifth Edition)", the acupoints are selected as follows: GV20(Baihui), HT7(Shenmen), SP6(Sanyinjiao), KI6(Zhaohai), BL62(Shenmai), EX-HN22(Anmian), using a 0.3 mm×40 mm needle straight insert in skin with depth of 0.5-1.0 cun. After twisting to get qi, the researcher will manipulate the needle, and keep the needle in acupoints for 30 minutes.

Outcome Measures

Primary Outcome Measures

  1. Pittsburgh sleep quality index [Before treatment]

    Use the PSQI score table to evaluate according to patient's situation, and analyze the score changes of the subjects' insomnia degree before and after treatment by the analysis of score data. The PSQI consists of 19 self-rated questions and 5 questions rated by sleep partners. The 19 self-assessment questions constitute 7 factors ranging from 0 to 3 points. The cumulative score of each factor component is the total score of the PSQI, and the total score ranges from 0 to 21. The higher the score, the worse the sleep quality.

  2. Pittsburgh sleep quality index [the 4th week of treatment]

    Use the PSQI score table to evaluate according to patient's situation, and analyze the score changes of the subjects' insomnia degree before and after treatment by the analysis of score data. The PSQI consists of 19 self-rated questions and 5 questions rated by sleep partners. The 19 self-assessment questions constitute 7 factors ranging from 0 to 3 points. The cumulative score of each factor component is the total score of the PSQI, and the total score ranges from 0 to 21. The higher the score, the worse the sleep quality.

  3. Pittsburgh sleep quality index [4 weeks after treatment]

    Use the PSQI score table to evaluate according to patient's situation, and analyze the score changes of the subjects' insomnia degree before and after treatment by the analysis of score data.The PSQI consists of 19 self-rated questions and 5 questions rated by sleep partners. The 19 self-assessment questions constitute 7 factors ranging from 0 to 3 points. The cumulative score of each factor component is the total score of the PSQI, and the total score ranges from 0 to 21. The higher the score, the worse the sleep quality.

Secondary Outcome Measures

  1. Fatigue Scale-14 [Before treatment]

    Respond to the severity of fatigue from different angles through 14 questions.The Fatigue Scale-14 is composed of 14 items, and the 14 items are divided into two categories. One category reflects physical fatigue, including 1 to 8 items; the other reflects mental fatigue, including 9 to 14 in total 6 items. The highest score for physical fatigue is 8, the highest score for mental fatigue is 6, and the highest total score is 14. The higher the score, the more severe the fatigue.

  2. Fatigue Scale-14 [the 4th week of treatment]

    Respond to the severity of fatigue from different angles through 14 questions.The Fatigue Scale-14 is composed of 14 items, and the 14 items are divided into two categories. One category reflects physical fatigue, including 1 to 8 items; the other reflects mental fatigue, including 9 to 14 in total 6 items. The highest score for physical fatigue is 8, the highest score for mental fatigue is 6, and the highest total score is 14. The higher the score, the more severe the fatigue.

  3. Fatigue Scale-14 [4 weeks after treatment]

    Respond to the severity of fatigue from different angles through 14 questions.The Fatigue Scale-14 is composed of 14 items, and the 14 items are divided into two categories. One category reflects physical fatigue, including 1 to 8 items; the other reflects mental fatigue, including 9 to 14 in total 6 items. The highest score for physical fatigue is 8, the highest score for mental fatigue is 6, and the highest total score is 14. The higher the score, the more severe the fatigue.

  4. Epworth Sleepiness Scale [Before treatment]

    The epworth sleepiness scale is applied to assess excessive daytime sleepiness. The clinical significance of this table is: sleepiness can be semi-objectively assessed by the epworth sleepiness scale. Any sleep disorder caused by sleep deprivation may lead to change of this scale. This scale has 24 points. A score greater than 6 indicates drowsiness, a score greater than 11 indicates excessive sleepiness, and a score greater than 16 indicates dangerous drowsiness.

  5. Epworth Sleepiness Scale [he 4th week of treatment]

    The epworth sleepiness scale is applied to assess excessive daytime sleepiness. The clinical significance of this table is: sleepiness can be semi-objectively assessed by the epworth sleepiness scale. Any sleep disorder caused by sleep deprivation may lead to change of this scale. This scale has 24 points. A score greater than 6 indicates drowsiness, a score greater than 11 indicates excessive sleepiness, and a score greater than 16 indicates dangerous drowsiness.

  6. Epworth Sleepiness Scale [4 weeks after treatment]

    The epworth sleepiness scale is applied to assess excessive daytime sleepiness. The clinical significance of this table is: sleepiness can be semi-objectively assessed by the epworth sleepiness scale. Any sleep disorder caused by sleep deprivation may lead to change of this scale. This scale has 24 points. A score greater than 6 indicates drowsiness, a score greater than 11 indicates excessive sleepiness, and a score greater than 16 indicates dangerous drowsiness.

  7. Self-Rating Anxiety Scale [Before treatment]

    SAS is called anxiety self-rating scale, which is a standard for anxiety assessment and a psychological scale used to measure the degree of anxiety state and its changes during treatment. The SAS scale has 100 points in total, and the cut-off value is 50 points, of which 50-59 points are mild anxiety, 60-69 points are moderate anxiety, and more than 70 points are severe anxiety.

  8. Self-Rating Anxiety Scale [4th week of treatment]

    SAS is called anxiety self-rating scale, which is a standard for anxiety assessment and a psychological scale used to measure the degree of anxiety state and its changes during treatment. The SAS scale has 100 points in total, and the cut-off value is 50 points, of which 50-59 points are mild anxiety, 60-69 points are moderate anxiety, and more than 70 points are severe anxiety.

  9. Self-Rating Anxiety Scale [4 weeks after treatment]

    SAS is called anxiety self-rating scale, which is a standard for anxiety assessment and a psychological scale used to measure the degree of anxiety state and its changes during treatment. The SAS scale has 100 points in total, and the cut-off value is 50 points, of which 50-59 points are mild anxiety, 60-69 points are moderate anxiety, and more than 70 points are severe anxiety.

  10. Self-rating depression scale [Before treatment]

    The depression self-rating scale is a standard for depression assessment, which can quite intuitively reflect the subjective feelings of depressed patients during treatment. It is mainly applicable to adults with depressive symptoms, including outpatients and inpatients. The SDS scale has 100 points in total, and the cut-off value is 53 points, of which 53-62 points are mild anxiety, 63-72 points are moderate anxiety, and more than 73 points are severe anxiety.

  11. Self-rating depression scale [the 4th week of treatment]

    The depression self-rating scale is a standard for depression assessment, which can quite intuitively reflect the subjective feelings of depressed patients during treatment. It is mainly applicable to adults with depressive symptoms, including outpatients and inpatients. The SDS scale has 100 points in total, and the cut-off value is 53 points, of which 53-62 points are mild anxiety, 63-72 points are moderate anxiety, and more than 73 points are severe anxiety.

  12. Self-rating depression scale [4 weeks after treatment]

    The depression self-rating scale is a standard for depression assessment, which can quite intuitively reflect the subjective feelings of depressed patients during treatment. It is mainly applicable to adults with depressive symptoms, including outpatients and inpatients. The SDS scale has 100 points in total, and the cut-off value is 53 points, of which 53-62 points are mild anxiety, 63-72 points are moderate anxiety, and more than 73 points are severe anxiety.

  13. Polysomnography [the 4th week of treatment]

    Polysomnography refers to the continuous and synchronous acquisition, recording and analysis of EEG, electrooculogram, electromyogram, oronasal airflow, respiratory effort, and saturation of oxygen levels, body position and other physiological and pathological parameters during sleep by sleep technicians all night through computer software in the sleep laboratory. This technology for the diagnosis of sleep disorders is the gold standard for the diagnosis and treatment of sleep disorders.

  14. Heart rate variability [the 4th week of treatment]

    Heart rate variability (HRV) refers to the fluctuations in the interval between successive heartbeats. It is commonly used to evaluate the regulatory role of the autonomic nervous system on cardiac activity. It is an important noninvasive indicator for evaluating autonomic nervous activity, and is also one of the important indicators for evaluating autonomic nervous changes during sleep.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Conforming to the diagnostic criteria of traditional Chinese and Western medicine for chronic insomnia;

  • Age range: 18-70 years old;

  • PSQI score>7 points;

  • No communication and cognitive impairment;

  • No use or withdrawal of psychoactive drugs such as anti-anxiety within one month; ·No major physical diseases;

  • Those who voluntarily accept the research content and can complete various scale evaluations, polysomnography monitoring and HRV;

  • Sign an informed consent form prior to the start of the study.

Exclusion Criteria:
  • Those who do not meet the inclusion criteria;

  • Persons with a history of severe mental illness, severe head injury, and significant disturbance of consciousness;

  • Those with severe liver and renal insufficiency and bleeding tendencies;

  • Alcoholism (liquor ≥ 100ml/day), smoking (≥ 15 cigarettes/day), drug abuse or taking psychotropic drugs;

  • People with other sleep disorders, such as sleep apnea hypopnea syndrome, paroxysmal sleeping sickness, and REM sleep behavioral disorders;

  • Pregnant or nursing;

  • Those with other major diseases and poor control;

  • Other persons who are unwilling to sign informed consent.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The Third Affiliated hospital of Zhejiang Chinese Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Liu Yingjun, Attending doctor, The Third Affiliated hospital of Zhejiang Chinese Medical University
ClinicalTrials.gov Identifier:
NCT05830877
Other Study ID Numbers:
  • 2023ZL476
First Posted:
Apr 26, 2023
Last Update Posted:
Apr 27, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Liu Yingjun, Attending doctor, The Third Affiliated hospital of Zhejiang Chinese Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2023